FGFR4 and pancreatic ductal adenocarcinoma: Research on pancreatic ductal adenocarcinoma cells [211] demonstrated effectiveness of a selective fibroblast growth factor receptor 4 (FGFR4) inhibitor—BLU9931—in the induction of senescence.